CASEBIA Trademark

Trademark Overview

On Thursday, June 23, 2016, a trademark application was filed for CASEBIA with the United States Patent and Trademark Office. The USPTO has given the CASEBIA trademark a serial number of 87082178. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 16, 2020. This trademark is owned by Casebia Therapeutics Limited Liability Partnership. The CASEBIA trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
casebia

General Information

Serial Number87082178
Word MarkCASEBIA
Filing DateThursday, June 23, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 16, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "CASEBIA", appearing directly below the images of a circle, square and pentagon, presented in an overlapping vertical arrangement.
Goods and ServicesGene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 29, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCasebia Therapeutics Limited Liability Partnership
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAscot, Berkshire SL57HL
GB
Party NameCasebia Therapeutics Limited Liability Partnership
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC4A3TW
GB

Trademark Events

Event DateEvent Description
Monday, March 16, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 16, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 10, 2020EXTENSION 5 GRANTED
Thursday, July 18, 2019EXTENSION 5 FILED
Thursday, July 18, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 18, 2019TEAS EXTENSION RECEIVED
Thursday, January 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 15, 2019EXTENSION 4 GRANTED
Tuesday, January 15, 2019EXTENSION 4 FILED
Tuesday, January 15, 2019TEAS EXTENSION RECEIVED
Thursday, July 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 24, 2018EXTENSION 3 GRANTED
Tuesday, July 24, 2018EXTENSION 3 FILED
Tuesday, July 24, 2018TEAS EXTENSION RECEIVED
Monday, April 9, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 9, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 10, 2018EXTENSION 2 GRANTED
Wednesday, January 10, 2018EXTENSION 2 FILED
Wednesday, January 10, 2018TEAS EXTENSION RECEIVED
Thursday, August 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2017CORRECTED NOA E-MAILED
Wednesday, August 9, 2017DIVISIONAL PROCESSING COMPLETE
Monday, July 17, 2017DIVISIONAL REQUEST RECEIVED
Monday, July 17, 2017TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 9, 2017EXTENSION 1 GRANTED
Monday, July 17, 2017EXTENSION 1 FILED
Tuesday, August 8, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 17, 2017TEAS EXTENSION RECEIVED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 5, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, October 30, 2016ASSIGNED TO LIE
Tuesday, October 18, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 4, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, October 4, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 4, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, October 4, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, September 29, 2016ASSIGNED TO EXAMINER
Thursday, June 30, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 27, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

casebia gene treatment diseases disorders namely therapy products hematologic urological psychiatric